Next generation diagnostics transforming the trajectory of the healthcare industry

2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, at the core of our response to the global pandemic, remarkable advancements were made in another great frontier in healthcare.

Frost & Sullivan has identified the top opportunities to flourish in the global next generation diagnostics market with insights by Amartya Bose, Healthcare & Life Sciences Industry Analyst.